VOYA Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Sell
58,546
-2,269
-4% -$565K 0.01% 555
2025
Q4
$14.6M Buy
60,815
+28,049
+86% +$7.17M 0.01% 568
2025
Q3
$8.97M Sell
32,766
-19,792
-38% -$5.41M 0.01% 691
2025
Q2
$13.6M Sell
52,558
-2,646
-5% -$631K 0.01% 646
2025
Q1
$12.4M Sell
55,204
-539
-1% -$126K 0.01% 672
2024
Q4
$12.7M Sell
55,743
-2,806
-5% -$676K 0.01% 674
2024
Q3
$14.3M Sell
58,549
-4,143
-7% -$926K 0.01% 654
2024
Q2
$12M Sell
62,692
-27,901
-31% -$5.66M 0.01% 698
2024
Q1
$17.9M Sell
90,593
-2,771
-3% -$508K 0.02% 577
2023
Q4
$16.1M Sell
93,364
-3,543
-4% -$544K 0.02% 586
2023
Q3
$14.3M Sell
96,907
-138,214
-59% -$25M 0.02% 588
2023
Q2
$51.4M Sell
235,121
-95,029
-29% -$21.2M 0.05% 327
2023
Q1
$72.3M Sell
330,150
-4,365
-1% -$947K 0.08% 283
2022
Q4
$69.6M Sell
334,515
-29,179
-8% -$6.41M 0.08% 281
2022
Q3
$79.4M Buy
363,694
+109,209
+43% +$24.9M 0.1% 246
2022
Q2
$53.3M Buy
254,485
+155,676
+158% +$33.1M 0.13% 152
2022
Q1
$24M Sell
98,809
-2,061
-2% -$499K 0.05% 307
2021
Q4
$26.3M Buy
100,870
+22,920
+29% +$5.95M 0.05% 302
2021
Q3
$20.5M Sell
77,950
-1,708
-2% -$467K 0.04% 318
2021
Q2
$19.6M Sell
79,658
-7,270
-8% -$1.53M 0.04% 352
2021
Q1
$16.9M Sell
86,928
-3,731
-4% -$748K 0.03% 396
2020
Q4
$19.3M Sell
90,659
-5,184
-5% -$1.03M 0.04% 354
2020
Q3
$16.4M Sell
95,843
-3,011
-3% -$556K 0.04% 378
2020
Q2
$19M Buy
98,854
+7,359
+8% +$1.2M 0.04% 343
2020
Q1
$13.5M Sell
91,495
-1,133
-1% -$180K 0.04% 394
2019
Q4
$14.4M Buy
92,628
+12,197
+15% +$1.76M 0.03% 492
2019
Q3
$10.9M Buy
80,431
+452
+0.6% +$59.2K 0.02% 576
2019
Q2
$9.76M Buy
79,979
+2,948
+4% +$327K 0.02% 617
2019
Q1
$8.01M Sell
77,031
-1,715
-2% -$177K 0.02% 654
2018
Q4
$8.97M Buy
78,746
+90
+0.1% +$9.64K 0.02% 566
2018
Q3
$9.07M Sell
78,656
-27,871
-26% -$3.05M 0.02% 635
2018
Q2
$11M Sell
106,527
-2,069
-2% -$209K 0.02% 574
2018
Q1
$10.7M Buy
108,596
+22,278
+26% +$2.11M 0.02% 566
2017
Q4
$7.31M Sell
86,318
-4,011
-4% -$331K 0.02% 709
2017
Q3
$6.95M Buy
90,329
+19,914
+28% +$1.52M 0.01% 713
2017
Q2
$5.48M Sell
70,415
-28,792
-29% -$2.06M 0.01% 775
2017
Q1
$7.14M Sell
99,207
-2,421
-2% -$167K 0.02% 696
2016
Q4
$6.31M Buy
101,628
+17,736
+21% +$1.09M 0.02% 727
2016
Q3
$5.43K Sell
83,892
-20,084
-19% -$1.34M 0.01% 772
2016
Q2
$6.57M Sell
103,976
-27,933
-21% -$1.65M 0.02% 703
2016
Q1
$7.63M Buy
131,909
+53,437
+68% +$3.02M 0.02% 629
2015
Q4
$4.21M Buy
78,472
+4,999
+7% +$282K 0.01% 813
2015
Q3
$3.74M Sell
73,473
-7,009
-9% -$377K 0.01% 839
2015
Q2
$4.54M Sell
80,482
-8,359
-9% -$528K 0.01% 818
2015
Q1
$6.38M Buy
88,841
+21,197
+31% +$1.38M 0.01% 732
2014
Q4
$3.79M Sell
67,644
-3,633
-5% -$190K 0.01% 878
2014
Q3
$3.51M Sell
71,277
-702
-1% -$35.8K 0.01% 889
2014
Q2
$3.64M Sell
71,979
-64,149
-47% -$3.18M 0.01% 903
2014
Q1
$6.08M Buy
136,128
+525
+0.4% +$23.6K 0.01% 741
2013
Q4
$6.38M Sell
135,603
-894,970
-87% -$45.3M 0.01% 724
2013
Q3
$54.4M Buy
1,030,573
+118,109
+13% +$5.73M 0.14% 155
2013
Q2
$41.2M Buy
+912,464
New +$43.3M 0.11% 171

Other funds holding RMD

VOYA Investment Management's RMD Position: Q1 2026 in Review

VOYA Investment Management reduced its ResMed (RMD) stake by 3.7% in Q1 2026, selling an estimated $565K and leaving 58,546 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #555.

VOYA Investment Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.4M in Q3 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • VOYA Investment Management held 58,546 shares of ResMed worth $13.1M as of Q1 2026.
  • VOYA Investment Management sold 2,269 ResMed shares in Q1 2026, an estimated $565K.
  • ResMed made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #555 holding.
  • VOYA Investment Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's ResMed position peaked at $79.4M in Q3 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.